Low breadth — 0 expert voices, 0 KB claims. Case rests on filings, guidance, and quant
Position sizing
Satellite/tactical, ~2–3% — a cyclical re-rating candidate, not a core compounder
Next catalyst
2026-08-04 Q3 FY26 earnings (Street EPS ~$1.84)
Single biggest risk
Cyclical/government-budget exposure + an AI-infrastructure capex digestion that could stall the backlog
One-line thesis. Jacobs is a post-spin, asset-light engineering and consulting pure-play riding the data-center / semiconductor / water / energy build-out — record $27B backlog (1.4× book-to-bill), management raising FY26 guidance twice, adjusted EPS compounding mid-teens — but the GAAP numbers are muddied by the PA Consulting deal and the end-markets are cyclical, so it earns a tactical Buy at ~17–18× forward adjusted earnings, not a core conviction slot.
◆ Synthos call — WatchJ is a business we want at a price we don't have — it becomes a Buy below ~$136; until then, do nothing.
~16% forward adj-EPS CAGR, record $27B backlog (1.4× book-to-bill), margin expansion — but a services-margin business, not software.
Exponential Potential
4/10 · Moderate
Real AI-infrastructure / data-center tailwind, but linear people-based scaling caps the slope; growth steady, not accelerating.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 15%/yrTo justify today’s $128, earnings would have to compound roughly 15% a year for 10 years (9% discount rate). Analysts forecast ~10%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Jacobs is a giant engineering and consulting firm — the people who design and manage the building of data centers, chip factories, water systems, power grids, transit, and defense facilities. They don't own the buildings; they sell the brains that plan and run the projects. Right now they're riding the wave of everyone racing to build AI data centers and semiconductor plants, and their order book (backlog) just hit a record $27 billion.
Is the stock cheap or expensive? Fairly priced, leaning cheap. The reported "official" profit looks ugly this year because of a one-time charge from buying out a subsidiary (PA Consulting), but the underlying, cleaned-up earnings are growing about 15–20% a year, and you're paying roughly 17–18× those cleaned-up earnings — reasonable for a steady grower. The stock is also down about 22% from its high, so a lot of bad news may already be in the price.
Our verdict is Buy — Tactical: worth owning as a smaller, opportunistic position, not a set-and-forget cornerstone. The three scores in plain words:
Downside Risk 5/10 (middle). Low-drama stock (it doesn't swing wildly), but it carries some debt and its business rises and falls with construction and government spending.
Growth Quality 6/10 (good, not elite). Growing nicely with a fat order book, but it's a people-based service business — profit margins are thin-ish and it can't scale like software.
Exponential Potential 4/10 (modest). Real tailwind, but to do more work it mostly has to hire more people, which caps how fast it can explode.
The one big worry: a chunk of the work depends on government budgets and on the AI/data-center building boom continuing. If either cools off, the record backlog could stop growing.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago
Solid = J · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$127.89
Market cap$15B
P/E trailing6×
P/E FY26E / FY27E18× / 15×
EV / Sales1.4×
EV / EBITDA20.5×
Gross margin23.4%
Net margin2.9%
Dividend yield1.06%
Beta0.683
52-wk range$107 – $164
RSI(14)53
50 / 200-DMA$122 / $136
12-mo return+-4% (SPY +21%)
Street target$156 ($137–$175)
Analyst grades24 Buy · 14 Hold · 0 Sell
FMP ratingB-
Next earnings2026-08-05
What the experts actually said 0 traceable claims on J · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Jacobs Solutions (NYSE: J) is a ~$12B-revenue global engineering, design, consulting and program-management firm headquartered in Dallas, founded in 1947, ~43,000 employees. It plans, designs, engineers and manages the delivery of infrastructure and advanced-facility projects — and, through PA Consulting, does high-end management/tech consulting. Fiscal year ends late September.
Crucially, today's Jacobs is a very different company from three years ago. It has been reshaped by portfolio surgery: the cyclical/government-services businesses (Critical Mission Solutions, Divergent Solutions — now Amentum) were separated in late 2024, and Jacobs re-segmented into two continuing pieces. This is why the historical segment and revenue lines jump around in the data, and why trailing GAAP EPS is not a clean read.
Revenue mix (FY2025, from filings):
By segment: Infrastructure & Advanced Facilities $10.76B (89%) · PA Consulting $1.27B (11%). I&AF is the growth engine (data centers, semiconductors, water, energy & power, transportation); PA Consulting is a higher-margin consulting arm now fully owned.
By geography (continuing-ops detail): United States $7.42B (~63%) · Europe $2.87B (~24%) · Middle East & Africa $0.60B · Australia/NZ $0.57B · Canada $0.25B · India $0.18B · Asia $0.14B. US-weighted but meaningfully international.
The strategic story management keeps hammering: Jacobs sits at "a central position in the build-out of AI and related infrastructure" — i.e. the picks-and-shovels engineering firm for the data-center and semiconductor capex super-cycle, plus secular water and grid spend.
2. The expert thesis — no panel coverage (traceable)
There is no expert coverage of Jacobs Solutions in the Synthos knowledge base.total_claims = 0; zero net-bullish voices, zero cautionary voices, zero traceable claim_ids. Unlike our conviction-track names (e.g. Lilly, with 13 net-bullish voices and 251 reconciled claims), J did not enter through expert conviction. It enters on the quant/fundamental screen.
Accordingly, every judgment in this note is fundamentals- and quant-driven — built from FMP financials, live analyst estimates, and management's own SEC-filed guidance (§9, half-weighted). We will not manufacture conviction we do not have. The Street, for what it is worth as context, is constructive: 24 Buy / 14 Hold / 0 Sell, consensus target $156.13. But that is sell-side context, not the independent expert signal Synthos exists to surface — treat this as a data-and-guidance call.
3. Synthos scores & the Bull / Base / Bear cases
Three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
5 · Moderate
Low beta (0.68) and a record 1.4× book-to-bill backlog cushion the downside, but reported net-debt/EBITDA ~3.5× (distorted by the PA charge; ~1.5–2× on adjusted EBITDA), messy post-spin GAAP, and cyclical/government end-markets keep it mid-pack.
Growth Quality
6 · Good
~16% forward adjusted-EPS CAGR, record backlog, expanding adjusted EBITDA margin (guided 14.6–14.9%), a real secular tailwind — but it's a people-based services model with ~23% gross / mid-single-digit net margins, not a high-return software compounder.
Exponential Potential
4 · Modest
The AI-infrastructure / data-center tailwind is real, but engineering headcount scales linearly and growth is steady, not accelerating; a $15B cap has room, yet the slope is capped by the delivery model.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities; the cases bound the range and the scores summarize them. All EPS figures are adjusted (the GAAP line is noise this year).
Case
Key assumptions
Fair value
Bull
AI/data-center + semiconductor capex stays hot; backlog keeps compounding; PA synergies land. FY27E adj-EPS beats to ~$9.0 (vs $8.27 cons); market awards a growth ~19× multiple.
~$175 (+37%)
Base(our anchor)
Guidance roughly holds — FY26 adj-EPS ~$7.24, FY27E ~$8.27; a steady mid-teens compounder with a record backlog earns a ~18× forward multiple.
~$150 (+17%)
Bear
AI-capex digestion or government-budget cuts stall the backlog; PA integration drags; margins disappoint. FY27E adj-EPS misses to ~$7.2; multiple de-rates to ~13×.
~$95 (−26%)
Synthos fair value = the base case, ~$150 (+17%), with the full $95–$175 span as the honest range. This sits just below the Street's $156 consensus — we broadly agree with the sell side here but discount slightly for cyclicality and the unproven durability of the AI-infrastructure order flow. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable steady growth) from exponentials (accelerating multi-baggers). Jacobs is a solid compounder, not an exponential:
Forward growth: adjusted-EPS CAGR FY26E→FY29E ~16.4% ($7.24 → $11.43); revenue CAGR is lower (revenue is partly a pass-through of subcontract cost — adjusted net revenue growth is the cleaner ~8–10.5% guided figure).
Acceleration (2nd derivative) is roughly flat, not positive. Adjusted EPS is guided to grow ~20% in FY26 then settle to mid-teens (FY27 +14%, FY28 +13%, FY29 +22% on 1–3 analysts). Backlog is the tell — record $27B and growing 22% y/y — but this is a broadening tailwind, not a self-reinforcing acceleration. Per our flagship philosophy we prize forward acceleration; J shows durability, not lift-off.
Room to run: at $15B market cap the name is far from a law-of-large-numbers ceiling, and the addressable market (global infrastructure + AI/data-center + water + grid capex) is enormous. So room is not the binding constraint —
…the binding constraint is the delivery model. Engineering/consulting scales with billable people. More revenue mostly means more hires, so incremental margins are bounded and the growth slope is structurally capped. That is why a genuinely large TAM still only earns a 4/10: the tailwind is real, the multiplier is not.
Exponential Potential: Modest. Own J for a steady mid-teens earnings compounder levered to a real capex super-cycle — not for a fast multibagger. This framing is why it belongs in the satellite/tactical sleeve, not the core.
Revenue: FY25 $12.03B, +4.6% (FY24 $11.50B; FY23 $10.85B). Gross revenue growth understates the story — much of it is pass-through subcontractor cost; management steers on adjusted net revenue (+8.8% y/y in Q2 FY26).
Backlog (the leading indicator):record $27.0B, +21.7% y/y, TTM book-to-bill 1.4× — i.e. winning work faster than burning it. This is the single most important forward tell for an E&C firm.
Margins: GAAP gross ~23.4% TTM; adjusted EBITDA margin guided 14.6–14.9% (of adjusted net revenue) and expanding. Net margin is thin (~3% TTM GAAP) and distorted this year.
The GAAP-vs-adjusted gap (read this carefully): Q2 FY26 posted a GAAP loss (−$0.32 EPS) while adjusted EPS was +$1.75 (+22.4% y/y). The loss was driven by PA Consulting acquisition transaction costs, not operations. Trailing GAAP EPS (~$3.26 TTM) and the resulting 39× P/E are misleading; the ~17.7× forward-adjusted multiple is the honest lens.
Balance sheet: net debt ~$1.47B. Reported net-debt/EBITDA ~3.5× is distorted by the depressed TTM GAAP EBITDA (the PA charge pushed Q2 EBITDA negative); against ~$1.7–1.8B of adjusted EBITDA, leverage is a manageable ~1.5–2×. Current ratio 1.43×. Investment-grade posture; ~$472M of buybacks YTD and a dividend raised 12.5%.
6. Valuation — priced in or room?
On trailing GAAP J looks expensive (39× EPS) — but that number is corrupted by the PA transaction charge and post-spin noise, so ignore it. On forward adjusted earnings, which is how management and the Street underwrite this business, the multiple is reasonable: ~17.7× FY26E ($7.24) → 15.5× FY27E ($8.27) → 13.7× FY28E ($9.36) → 11.2× FY29E ($11.43). EV/EBITDA ~20× TTM (again inflated by the charge), EV/sales just 1.4×. A ~17–18× forward multiple on a mid-teens compounder with a record backlog is fair, arguably slightly cheap — the classic "growth-at-a-reasonable-price" zone, especially with the stock 22% off its high. Street targets (context): consensus $156.13, high $175, low $137 — our $150 base is a touch below consensus because we haircut for cyclicality and AI-capex durability risk. Not a deep-value screen; a reasonably-priced steady grower in a beaten-down chart.
7. Technicals (from the FMP tech block)
Trend:mixed / basing. $127.89 sits above the 50-DMA ($121.89) but below the 200-DMA ($135.94) — the 50 under the 200 is a lingering downtrend posture, though price reclaiming the 50-DMA hints at a base.
Location:−22.2% off the 52-week high ($164.44), +19.2% off the 52-week low ($107.27); max drawdown from peak −22.2%. A name that has corrected hard and is trying to stabilize.
Relative strength (the honest tell): J is −3.6% over 12 months while SPY is +20.6% and QQQ +30.3% (−4.1% 3-mo vs SPY +13.7%). It has badly lagged — this is a contrarian/mean-reversion setup, not a momentum-leadership one.
Read: technicals argue for patience/scaling in. The reclaim of the 50-DMA is constructive, but a decisive move back above the 200-DMA (~$136) would confirm the turn. No urgency; accumulate on weakness.
8. Moat & competitive position
Jacobs' moat is reputation, scale, security clearances, and multi-year client relationships rather than a structural monopoly. Engineering News-Record ranks it the #1 Design Firm and #1 in Manufacturing — real brand equity in a business where clients de-risk mega-projects by hiring proven names. Barriers: technical depth across specialized verticals (semiconductors, water, nuclear/energy), a global delivery footprint, and a $27B backlog that locks in multi-year revenue. But it is a competitive, bid-based services industry — switching costs are moderate, pricing is disciplined by rivals, and margins are structurally capped by the labor model.
Peer set (FMP-supplied, market cap): the FMP peer list here is an imperfect algorithmic match — it skews to tech/software (Gartner $9.1B, SS&C $15.8B, Trimble $12.4B, Tyler Technologies $13.4B, CGI $14.4B, Nutanix $13.9B, GoDaddy $11.7B, Gen Digital $16.1B, Logitech $13.5B, Corpay $23.0B) rather than J's true engineering-and-construction comps (AECOM, WSP, Fluor, Stantec, Tetra Tech). Read the peer table with caution: on a true E&C basis Jacobs is a scale leader; against the software-heavy FMP list its ~17–18× forward multiple and mid-teens growth look average-to-cheap, but the comparison is apples-to-oranges.
9. Management, capital allocation & guidance
Capital allocation: balanced and shareholder-friendly — $472M of buybacks YTD, a 12.5% dividend raise, completion of the PA Consulting buy-in, and active optimization of the capital structure (lower weighted-average interest rate). Asset-light model (capex <1% of revenue) throws off real FCF.
Insider activity (a genuine positive): the sampled window shows open-market purchases by insiders, not just sales — CEO/Chair Robert Pragada bought 3,601 shares at $111.09 (2026-05-15) and director Manuel Fernandez bought 253 shares at $112.56 (2026-05-13). Insiders buying near the lows is a modest confidence signal; the only dispositions are routine tax-withholding (F-InKind) and equity awards.
Management's own guidance (half-weighted — their self-interested words): The 2026-05-05 Q2 FY26 8-K earnings release is a real, substantive release (revenue, backlog, explicit outlook). Management raised FY26 guidance for the second consecutive quarter: adjusted net revenue growth 8.0–10.5% (up from 6.5–10.0%), adjusted EBITDA margin 14.6–14.9% (up from 14.4–14.7%), adjusted EPS $7.10–$7.35 (up from $6.95–$7.30), adjusted FCF margin 7.0–8.5%. CFO stated they are "on track to reach or exceed all of our FY29 targets," crediting "accelerating top-line growth from our central position in the build-out of AI and related infrastructure." Weight this as management talking its own book — but the twice-raised guide plus a record backlog is a credible, corroborated signal, not just spin.
10. Catalysts & what to watch
Next earnings: 2026-08-04 (Q3 FY26; Street EPS ~$1.84). The key lines: backlog / book-to-bill (is the AI-infrastructure order flow still compounding?) and adjusted EBITDA margin (synergy delivery).
Backlog trajectory: any deceleration below ~1.2× book-to-bill would challenge the thesis.
AI / data-center & semiconductor capex: J's growth is levered to hyperscaler and chip-fab construction — watch for capex-digestion signals from that ecosystem.
PA Consulting integration: $20M+ synergy delivery within 24 months; margin follow-through.
Government budgets: transportation, water, and defense funding shifts (US and international).
Thesis tripwires (what would change the call): two consecutive quarters of backlog / book-to-bill decline; a cut to FY26/FY29 adjusted guidance; adjusted EBITDA margin slipping below ~14%; or a decisive technical breakdown back under the 52-week low.
11. Key risks
Cyclicality / end-market demand (structural): engineering demand tracks construction, capex cycles, and government budgets — a recession or an AI-capex pause hits the order book.
AI-infrastructure concentration: the growth narrative leans heavily on the data-center/semiconductor build-out; a capex digestion phase would remove the marquee tailwind.
Messy GAAP / integration: PA Consulting transaction charges muddy reported earnings and carry integration risk; investors relying on GAAP screens may misprice it either way.
Thin margins / labor model: a people-based services business with mid-single-digit net margins and wage inflation exposure — limited operating leverage.
Leverage optics: reported net-debt/EBITDA ~3.5× (distortion aside) plus goodwill/intangibles ~45% of assets leave less cushion than a fortress balance sheet.
No independent expert corroboration: the bull case rests on filings, guidance, and the sell side — Synthos has zero KB conviction here, so this is a lower-confidence call by construction.
12. Verdict, position sizing & monitoring
Buy — Tactical. Jacobs is a fairly-to-attractively priced (~17–18× forward adjusted EPS), asset-light engineering compounder with a record $27B backlog (1.4× book-to-bill), twice-raised FY26 guidance, insider buying near the lows, and a genuine secular tailwind in AI-infrastructure, semiconductor, water and grid build-out. The chart is beaten down (−22% off the high, lagging the market badly) — a contrarian/mean-reversion setup with real fundamental support. What holds it back from Core: cyclical, government-linked end-markets; a labor-scaled model that caps the growth slope; messy post-spin GAAP; and — importantly — no expert conviction in the Synthos KB. This is a data-and-guidance call, not a high-conviction one.
Sizing:satellite / tactical, ~2–3% — an opportunistic re-rating candidate, scaled in on weakness (the stock's own lag and the below-200-DMA posture argue against a single lump). A reclaim of the 200-DMA (~$136) would justify adding.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print, with backlog/book-to-bill as the primary tell. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $127.89.
Single biggest risk: a cyclical or AI-capex-digestion stall that freezes the record backlog — the whole thesis rides on that order flow continuing to compound.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — J has no expert coverage in the Synthos knowledge base. This note is explicitly fundamentals- and quant-driven; no claim_ids are cited because none exist. Fabricated conviction is structurally impossible (claim-ID reconciliation), and we state the absence of coverage plainly rather than dress up sell-side notes as conviction.
Data as-of: fundamentals 2026-03-27 (Q2 FY26) · estimates & prices 2026-07-02/03 · management guidance from the 2026-05-05 SEC 8-K (Item 2.02). Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
Management caveat: FY26 guidance is management's own book, half-weighted by design; corroborated here by a record backlog and twice-raised outlook.
GAAP caveat: trailing GAAP EPS and the derived P/E, EV/EBITDA and net-debt/EBITDA are distorted by PA Consulting transaction charges and the Amentum separation; adjusted metrics are used where noted.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").